EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia

Jianping Li, Yimeng Shi, Baohang Zhang, Wenrui Yang, Liping Jing, Li Zhang, Bing Han, Jun Shi, Weiping Yuan, Sidan Li, Fengkui Zhang, Xin Zhao

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06335-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Jianping Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clin…. Hauptthemen laut MEDLINE: Anemia, Aplastic, Receptors, Thrombopoietin, Immunosuppressive Agents, Benzoates. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, Clinical and Translational Medicine Research Project of Chinese Academy of Medical Sciences, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Old individuals are at a high risk of developing aplastic anemia, and immunosuppressive therapy (IST) based on anti-human T-lymphocyte immunoglobulin (ATG) and cyclosporine (CsA) is recommended for treating severe aplastic anemia (SAA). Adding the thrombopoietin receptor agonist (TPO-RA) to IST could improve hematologic responses in patients with SAA; however, limited data exist for elder patients. Here, we report on the efficacy and prognostic factors associated with porcine ATG and CsA with or without TPO-RA as first-line therapy in elderly patients with SAA. Porcine ATG was administered intravenously at a dose of 20 mg/kg/d for 5 days. CsA was administered orally, maintaining plasma trough concentrations of 150-250 µg/L. Eltrombopag was administered at a dose of 75-150 mg/day, and hetrombopag was administered orally at a dose of 15 mg/day. One hundred and twenty-eight SAA patients, with a median age of 63 (60-73) years old, were included in this study, including 44 very severe aplastic anemia (VSAA) patients. All patients completed the porcine ATG treatment, and mild serum sicknesses were observed. Ten patients (2 SAA patients and 8 VSAA patients) died within 3 months of ATG initiation (early death), with severe infections being the main cause of death. Sixty-nine patients achieved a hematologic response at 6 months, with an overall response (OR) rate of 53.9%. The complete hematologic response (CR) rate at 6 months was 18.0%. The addition of TPO-RA to IST did not improve the OR and CR rates; nonetheless, early death was significantly lower (0%) in patients receiving TPO-RA compared to those not receiving TPO-RA (12%). Patients were followed up for a median of 28 (0.1-117) months. The OR rate at the last follow-up was 62.5%, while the CR rate was 36.7%. One patient progressed to myelodysplastic syndrome, one to leukemia, one to hemolytic paroxysmal nocturnal hemoglobinuria, and five developed clonal chromosomal abnormalities. The 2-year overall survival rate and failure-free survival rate were 86.0% (95% CI: 78.1-91.3%) and 70.5% (95% CI: 61.3-77.9%), respectively. A baseline neutrophil count of < 0.05 × 109/L was identified as an independent prognostic factor for early death. Age younger than 65 years, a baseline reticulocyte count of ≥ 7 × 109/L, and the absence of fever before and within 3 months following ATG treatment were independent predictors for hematologic response at 6 months. In conclusion, treatment with porcine ATG and CsA was safe and effective in elderly patients with SAA. An extremely low baseline neutrophil count indicated a high risk of early death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticReceptors, ThrombopoietinImmunosuppressive AgentsBenzoatesAntilymphocyte SerumCyclosporinePyrazolesHydrazinesHumansAgedFemaleMaleMiddle AgedAnimalsTreatment OutcomeDrug Therapy, CombinationSwine

Stichwörter der Autor:innen

ElderlyImmunosuppressive therapyPorcine ATGSevere aplastic anemiaThrombopoietin receptor agonist

Substanzen

Receptors, ThrombopoietinImmunosuppressive AgentseltrombopagBenzoatesAntilymphocyte SerumCyclosporinePyrazolesHydrazines

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sc…
  • Tianjin Institutes of Health Science, Tianjin, 301600, China.
  • Department of Hematology, Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.
  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Tianjin Institutes of Health Science, Tianjin, 301600, China. zhaoxin@ihcams.ac.cn.

Förderung

  • National Key R&D Program of China
  • Clinical and Translational Medicine Research Project of Chinese Academy of Medical Sciences
  • National High Level Hospital Clinical Research Funding
  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Shi, Y., Zhang, B., Yang, W., Jing, L., Zhang, L., Han, B., Shi, J., Yuan, W., Li, S., Zhang, F., & Zhao, X. (2025). The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia. Annals of Hematology. https://doi.org/10.1007/s00277-025-06335-9

Vancouver

Li J, Shi Y, Zhang B, Yang W, Jing L, Zhang L, et al. The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia. Annals of Hematology. 2025. doi:10.1007/s00277-025-06335-9

BibTeX
@article{Li2025,
  author = {Li, Jianping and Shi, Yimeng and Zhang, Baohang and Yang, Wenrui and Jing, Liping and Zhang, Li and Han, Bing and Shi, Jun and Yuan, Weiping and Li, Sidan and Zhang, Fengkui and Zhao, Xin},
  title = {The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06335-9}
}
Kostenlos starten →